Published in Lung Cancer on April 01, 2002
Peroxisome proliferator-activated receptor gamma overexpression suppresses growth and induces apoptosis in human multiple myeloma cells. Clin Cancer Res (2008) 1.06
PPAR gamma, bioactive lipids, and cancer progression. Front Biosci (Landmark Ed) (2012) 1.01
Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis. PLoS One (2011) 0.96
The pathophysiological function of peroxisome proliferator-activated receptor-gamma in lung-related diseases. Respir Res (2005) 0.96
Peroxisome proliferator-activated receptors and cancer: challenges and opportunities. Br J Pharmacol (2011) 0.95
Peroxisome proliferator-activated receptor-gamma inhibits transformed growth of non-small cell lung cancer cells through selective suppression of Snail. Neoplasia (2010) 0.92
Non-small-cell lung cancer: molecular targeted therapy and personalized medicine - drug resistance, mechanisms, and strategies. Pharmgenomics Pers Med (2013) 0.92
Activation and Molecular Targets of Peroxisome Proliferator-Activated Receptor-gamma Ligands in Lung Cancer. PPAR Res (2008) 0.89
Inhibitory effect of rosiglitazone on the acid-induced intracellular generation of hydrogen peroxide in cultured feline esophageal epithelial cells. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.86
Chemotherapy and chemoprevention by thiazolidinediones. Biomed Res Int (2015) 0.85
The Role of PPARgamma in the Cyclooxygenase Pathway in Lung Cancer. PPAR Res (2008) 0.84
Role of peroxisome proliferator-activated receptor gamma and its ligands in the treatment of hematological malignancies. PPAR Res (2008) 0.83
Peroxisome proliferator-activated receptor gamma overexpression and knockdown: impact on human B cell lymphoma proliferation and survival. Cancer Immunol Immunother (2008) 0.82
Comparative effects of fatty acids on endothelial inflammatory gene expression. Eur J Nutr (2007) 0.82
Polymorphisms of peroxisome proliferator-activated receptors and survival of lung cancer and upper aero-digestive tract cancers. Lung Cancer (2014) 0.81
Anti- and Protumorigenic Effects of PPARγ in Lung Cancer Progression: A Double-Edged Sword. PPAR Res (2012) 0.77
The use of Cox-2 and PPARγ signaling in anti-cancer therapies. Exp Ther Med (2010) 0.76
Down-regulated expressions of PPARγ and its coactivator PGC-1 are related to gastric carcinogenesis and Lauren's classification in gastric carcinoma. Chin J Cancer Res (2013) 0.76
Effects of PPARγ agonistrosiglitazone on human retinoblastoma cell in vitro and in vivo. Int J Clin Exp Pathol (2015) 0.75
EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science (2004) 61.56
Characterizing the cancer genome in lung adenocarcinoma. Nature (2007) 16.48
miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer. Cancer Res (2008) 2.80
EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas. Lung Cancer (2008) 2.40
Involvement of histone H1.2 in apoptosis induced by DNA double-strand breaks. Cell (2003) 2.38
RNASEN regulates cell proliferation and affects survival in esophageal cancer patients. Clin Cancer Res (2006) 2.21
PIK3CA mutation status in Japanese lung cancer patients. Lung Cancer (2006) 2.15
microRNA expression profile in undifferentiated gastric cancer. Int J Oncol (2009) 1.95
Epidermal growth factor receptor gene mutation defines distinct subsets among small adenocarcinomas of the lung. Lung Cancer (2006) 1.78
Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler. Oncol Rep (2007) 1.62
Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade. J Thorac Oncol (2011) 1.53
EGFR Mutation status in Japanese lung cancer patients: genotyping analysis using LightCycler. Clin Cancer Res (2005) 1.47
Immunohistochemical evaluation of hormone receptor status for predicting response to endocrine therapy in metastatic breast cancer. Breast Cancer (2006) 1.42
Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma. Oncol Rep (2007) 1.42
Successful delivery derived from vitrified-warmed spermatozoa from a patient with nonobstructive azoospermia. Fertil Steril (2012) 1.41
EGFR and erbB2 mutation status in Japanese lung cancer patients. Int J Cancer (2006) 1.40
Preservation of phrenic nerve involved by stage III thymoma. Ann Thorac Surg (2010) 1.38
Thoracic and cardiovascular surgery in Japan during 2009: annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg (2011) 1.35
Usefulness and complications of computed tomography-guided lipiodol marking for fluoroscopy-assisted thoracoscopic resection of small pulmonary nodules: experience with 174 nodules. J Thorac Cardiovasc Surg (2006) 1.34
EGFR exon 20 insertion mutation in Japanese lung cancer. Lung Cancer (2007) 1.32
Met gene copy number predicts the prognosis for completely resected non-small cell lung cancer. Cancer Sci (2008) 1.31
PIK3CA gene amplification in Japanese non-small cell lung cancer. Lung Cancer (2007) 1.30
Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR. Med Mol Morphol (2009) 1.30
Expression of PTTG (pituitary tumor transforming gene) in esophageal cancer. Jpn J Clin Oncol (2002) 1.29
Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers. Oncogene (2002) 1.29
Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay. Lung Cancer (2005) 1.28
Intrathoracic lipomas: their clinicopathological behaviors are not as straightforward as expected. Ann Thorac Surg (2008) 1.28
Low phosphorylation of estrogen receptor alpha (ERalpha) serine 118 and high phosphorylation of ERalpha serine 167 improve survival in ER-positive breast cancer. Endocr Relat Cancer (2008) 1.25
Thoracic and cardiovascular surgery in Japan during 2008: annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg (2010) 1.24
Thymic carcinoma: 30 cases at a single institution. J Thorac Oncol (2008) 1.22
Carbon nanotube growth from diamond. J Am Chem Soc (2009) 1.21
Prognostic significance of [(18)F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma. Cancer (2006) 1.19
Cten mRNA expression was correlated with tumor progression in lung cancers. Lung Cancer (2003) 1.18
Thoracic and cardiovascular surgery in Japan during 2006: annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg (2008) 1.18
Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer. Carcinogenesis (2002) 1.18
Uncommon V599E BRAF mutations in Japanese patients with lung cancer. J Surg Res (2005) 1.16
Sclerosing hemangioma with metastases to multiple nodal stations. Ann Thorac Surg (2002) 1.16
Histone deacetylase 1 mRNA expression in lung cancer. Lung Cancer (2004) 1.14
Expression of the periostin mRNA level in neuroblastoma. J Pediatr Surg (2002) 1.14
Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002. J Thorac Oncol (2010) 1.13
Intrapulmonary localized fibrous tumor of the lung: a very unusual presentation. Ann Thorac Surg (2008) 1.13
Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells. Oncogene (2003) 1.13
A clinicopathological study of resected pulmonary nodules with focal pure ground-glass opacity. Eur J Cardiothorac Surg (2006) 1.12
Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer. Breast Cancer Res (2005) 1.12
Epidermal growth factor receptor gene mutation and computed tomographic findings in peripheral pulmonary adenocarcinoma. J Thorac Oncol (2006) 1.09
Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers. BMC Cancer (2008) 1.09
Expression of estrogen receptor beta wild-type and its variant ERbetacx/beta2 is correlated with better prognosis in breast cancer. Jpn J Clin Oncol (2007) 1.09
Cten mRNA expression is correlated with tumor progression in thymoma. Tumour Biol (2004) 1.08
Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients. Breast Cancer Res (2007) 1.08
Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer. Breast Cancer Res Treat (2011) 1.07
Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis. J Exp Clin Cancer Res (2010) 1.07
Thoracic and cardiovascular surgery in Japan during 2007. Annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg (2009) 1.07
Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer. Cancer Lett (2003) 1.05
Expression of the MTA1 mRNA in advanced lung cancer. Lung Cancer (2002) 1.05
Middle lobe preservation and fixation: right upper and lower sleeve bilobectomy. How to do it. Surg Today (2012) 1.05
The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma. Oncol Rep (2007) 1.04
Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis. Gen Thorac Cardiovasc Surg (2008) 1.04